LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 12 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 2. - Dataset (ID:20249)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|
Hs 578T | WYE-125132 | 0.12 | uM | LJP6 | 72 | hr | 765 | 997 | 3101 | 0.3216 | 0.1400 |
Hs 578T | WYE-125132 | 0.37 | uM | LJP6 | 72 | hr | 765 | 923 | 3101 | 0.2976 | 0.0973 |
Hs 578T | WYE-125132 | 1.11 | uM | LJP6 | 72 | hr | 765 | 871 | 3101 | 0.2812 | 0.0664 |
Hs 578T | WYE-125132 | 3.33 | uM | LJP6 | 72 | hr | 765 | 875 | 3101 | 0.2824 | 0.0691 |
Hs 578T | WYE-125132 | 10 | uM | LJP6 | 72 | hr | 765 | 658 | 3101 | 0.2124 | -0.0717 |
Hs 578T | Barasertib | 0.04 | uM | LJP5 | 72 | hr | 765 | 1128 | 3148 | 0.3586 | 0.2095 |
Hs 578T | Barasertib | 0.12 | uM | LJP5 | 72 | hr | 765 | 1128 | 3148 | 0.3584 | 0.2096 |
Hs 578T | Barasertib | 0.37 | uM | LJP5 | 72 | hr | 765 | 1089 | 3148 | 0.3460 | 0.1890 |
Hs 578T | Barasertib | 1.11 | uM | LJP5 | 72 | hr | 765 | 1005 | 3148 | 0.3194 | 0.1434 |
Hs 578T | Barasertib | 3.33 | uM | LJP5 | 72 | hr | 765 | 945 | 3148 | 0.3003 | 0.1090 |
Hs 578T | Barasertib | 10 | uM | LJP5 | 72 | hr | 765 | 863 | 3148 | 0.2742 | 0.0610 |
Hs 578T | Vemurafenib | 0.04 | uM | LJP5 | 72 | hr | 765 | 3316 | 3148 | 1.0533 | 1.0516 |
Hs 578T | Vemurafenib | 0.12 | uM | LJP5 | 72 | hr | 765 | 3257 | 3148 | 1.0348 | 1.0338 |
Hs 578T | Vemurafenib | 0.37 | uM | LJP5 | 72 | hr | 765 | 3287 | 3148 | 1.0441 | 1.0427 |
Hs 578T | Vemurafenib | 1.11 | uM | LJP5 | 72 | hr | 765 | 3290 | 3148 | 1.0453 | 1.0439 |
Hs 578T | Vemurafenib | 3.33 | uM | LJP5 | 72 | hr | 765 | 3014 | 3148 | 0.9575 | 0.9579 |
Hs 578T | Vemurafenib | 10 | uM | LJP5 | 72 | hr | 765 | 1944 | 3148 | 0.6177 | 0.5793 |
Hs 578T | Enzastaurin | 0.04 | uM | LJP5 | 72 | hr | 765 | 3127 | 3148 | 0.9934 | 0.9934 |
Hs 578T | Enzastaurin | 0.12 | uM | LJP5 | 72 | hr | 765 | 3078 | 3148 | 0.9778 | 0.9781 |
Hs 578T | Enzastaurin | 0.37 | uM | LJP5 | 72 | hr | 765 | 3051 | 3148 | 0.9693 | 0.9695 |
Hs 578T | Enzastaurin | 1.11 | uM | LJP5 | 72 | hr | 765 | 3109 | 3148 | 0.9878 | 0.9879 |
Hs 578T | Enzastaurin | 3.33 | uM | LJP5 | 72 | hr | 765 | 3135 | 3148 | 0.9958 | 0.9958 |
Hs 578T | Enzastaurin | 10 | uM | LJP5 | 72 | hr | 765 | 3043 | 3148 | 0.9666 | 0.9670 |
Hs 578T | Palbociclib | 0.04 | uM | LJP6 | 72 | hr | 765 | 2272 | 3101 | 0.7326 | 0.7144 |
Hs 578T | Palbociclib | 0.12 | uM | LJP6 | 72 | hr | 765 | 1946 | 3101 | 0.6273 | 0.5875 |